419
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Olmesartan-associated enteropathy: new insights on the natural history? Report of two cases

, , , , , & show all
Pages 152-156 | Received 30 Jun 2015, Accepted 16 Jul 2015, Published online: 20 Aug 2015

References

  • DeGaetani M, Tennyson CA, Lebwohl B, Lewis SK, Abu Daya H, Arguelles-Grande C, et al. Villous atrophy and negative celiac serology: a diagnostic and therapeutic dilemma. Am J Gastroenterol 2013;108:647–53.
  • Biagi F, Lorenzini P, Corazza GR. Literature review on the clinical relationship between ulcerative jejunoileitis, coeliac disease and enteropathy associated T cell lymphoma. Scand J Gastroenterol 2000;35:785–90.
  • Malamut G, Afchain P, Verkarre V, Lecomte T, Amiot A, Damotte D, et al. Presentation and long-term follow-up of refractory celiac disease: comparison of type I with type II. Gastroenterology 2009;136:81–90.
  • Weinstein WM, Saunders DR, Tytgat GN, Rubin CE. Collagenous sprue—an unrecognized type of malabsorption. N Engl J Med 1970;283:1297–301.
  • Martucci S, Biagi F, Di Sabatino A, Corazza GR. Coeliac disease. Dig Liver Dis 2002;34(Suppl. 2):S150–3
  • Ludvigsson JF, Bai JC, Biagi F, Card TR, Ciacci C, Ciclitira PJ, et al. Diagnosis and management of adult coeliac disease – guidelines from the British Society of Gastroenterology. Gut 2014;63:1210–28.
  • Biagi F, Corazza GR. Defining “gluten refractory enteropathy”. Eur J Gastroenterol Hepat 2001;13:561–5.
  • Corazza GR, Biagi F, Volta U, Andreani ML, De Franceschi L, Gasbarrini G. Autoimmune enteropathy and villous atrophy in adults. Lancet 1997;350:106–9.
  • Akram S, Murray JA, Pardi DS, Alexander GL, Schaffner JA, Russo PA, et al. Adult autoimmune enteropathy: Mayo Clinic Rochester experience. Clin Gastroenterol Hepatol 2007;5:1282–90.
  • Malamut G, Verkarre V, Suarez F, Viallard JF, Lascaux AS, Cosnes J, et al. The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol 2010;105:2262–75.
  • Biagi F, Bianchi PI, Zilli A, Marchese A, Luinetti O, Lougaris V, et al. The significance of duodenal mucosal atrophy in patients with common variable immunodeficiency: a clinical and histopathologic study. Am J Clin Pathol 2012;138:185–9.
  • Boscá MM, Añón R, Mayordomo E, Villagrasa R, Balza N, Amorós C, et al. Methotrexate induced sprue-like syndrome. World J Gastroenterol 2008;14:7009–11.
  • Kamar N, Faure P, Dupuis E, Cointault O, Joseph-Hein K, Durand D, et al. Villous atrophy induced by mycophenolate mofetil in renal-transplant patients. Transpl Int 2004;17:463–7.
  • Ziegler TR, Fernández-Estívariz C, Gu LH, Fried MW, Leader LM. Severe villous atrophy and chronic malabsorption induced by azathioprine. Gastroenterology 2003;124:1950–7.
  • Green PH, Tall AR. Drugs, alcohol and malabsorption. Am J Med 1979;67:1066–76.
  • Peacey SR, Walls WD. Steatorrhoea and sub-total villous atrophy complicating mefenamic acid therapy. Br J Clin Pract 1992;46:211.
  • Rubio-Tapia A, Herman ML, Ludvigsson JF, Kelly DG, Mangan TF, Wu TT, et al. Severe spruelike enteropathy associated with olmesartan. Mayo Clin Proc 2012;87:732–8.
  • Scott LJ, McCormack PL. Olmesartan medoxomil: a review of its use in the management of hypertension. Drugs 2008;68:1239–72.
  • Haller H, Ito S, Izzo JL Jr, Januszewicz A, Katayama S, Menne J, et al. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. N Engl J Med 2011;364:907–17.
  • Werner C, Baumhäkel M, Teo KK, Schmieder R, Mann J, Unger T, et al. RAS blockade with ARB and ACE inhibitors: current perspective on rationale and patient selection. Clin Res Cardiol 2008;97:418–31.
  • Hartranft ME, Regal RE. A story with one happy ending: “triple phase” budesonide capsules for the treatment of olmesartan-induced enteropathy. Ann Pharmacother 2014;48:1234–7.
  • Marthey L, Cadiot G, Seksik P, Pouderoux P, Lacroute J, Skinazi F, et al. Olmesartan-associated enteropathy: results of a national survey. Aliment Pharmacol Ther 2014;40:1103–9.
  • Dedeoglu F. Drug-induced autoimmunity. Curr Opin Rheumatol 2009;21:547–51.
  • Chang C, Gershwin ME. Drug-induced lupus erythematosus: incidence, management and prevention. Drug Saf 2011;34:357–74.
  • Abeles AM, Abeles M. The clinical utility of a positive antinuclear antibody test result. Am J Med 2013;126:342–8.
  • Ianiro G, Bibbò S, Montalto M, Ricci R, Gasbarrini A, Cammarota G. Systematic review: sprue-like enteropathy associated with olmesartan. Aliment Pharmacol Ther 2014;40:16–23.
  • Herman M, Rubio-Tapia A, Marietta E; Wu TT, Murray J. Severe enteropathy in a patient on valsartan. Am J Gastroenterol 2013;108:S302.
  • Cyrany J, Vasatko T, Machac J, Nova M, Szanyi J, Kopacova M. Letter: telmisartan-associated enteropathy - is there any class effect? Aliment Pharmacol Ther 2014;40:569–70.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.